The new market access environment is value-driven. With shrinking health budgets – the drug budget is being more heavily scrutinised than ever before. To guarantee access, payers and HTA agencies need to know exactly what medicines will do in the ‘real world’ – EVEN with orphan drugs where small patient populations make evidence hard to come by. That’s why eyeforpharma have commissioned the exclusive whitepaper Real World Data: Sources & Applications.
You are here: / / Real World Data: Sources and Applications